168 related articles for article (PubMed ID: 38497192)
21. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
Gottlieb M; Carlson JN; Peksa GD
Cochrane Database Syst Rev; 2022 May; 5(5):CD013860. PubMed ID: 35588093
[TBL] [Abstract][Full Text] [Related]
23. Hydromorphone for cancer pain.
Bao YJ; Hou W; Kong XY; Yang L; Xia J; Hua BJ; Knaggs R
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011108. PubMed ID: 27727452
[TBL] [Abstract][Full Text] [Related]
24. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J
Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.
Simpson KN; Fossler MJ; Wase L; Demitrack MA
J Comp Eff Res; 2021 Oct; 10(15):1107-1119. PubMed ID: 34240625
[TBL] [Abstract][Full Text] [Related]
27. The safety and tolerability of the fentanyl HCl iontophoretic transdermal system: an alternative to currently available analgesic modalities.
Eberhart L
J Opioid Manag; 2007; 3(5):249-56. PubMed ID: 18181379
[TBL] [Abstract][Full Text] [Related]
28. Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials.
Wang L; Johnston B; Kaushal A; Cheng D; Zhu F; Martin J
Can J Anaesth; 2016 Mar; 63(3):311-25. PubMed ID: 26659198
[TBL] [Abstract][Full Text] [Related]
29. The side effects of morphine and hydromorphone patient-controlled analgesia.
Hong D; Flood P; Diaz G
Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056
[TBL] [Abstract][Full Text] [Related]
30. Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series.
Veizi E; Tornero-Bold M; Hayek SM
Pain Pract; 2016 Jul; 16(6):E94-8. PubMed ID: 26990069
[TBL] [Abstract][Full Text] [Related]
31. Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Hammer GB; Khanna AK; Michalsky C; Wase L; Demitrack MA; Little R; Fossler MJ; Ayad S
Pain Ther; 2021 Dec; 10(2):1343-1353. PubMed ID: 34351590
[TBL] [Abstract][Full Text] [Related]
32. Randomized Controlled Trial of Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department.
Barnaby DP; Chertoff AE; Restivo AJ; Campbell CM; Pearlman S; White D; Bijur PE; Gallagher EJ
Ann Emerg Med; 2019 Feb; 73(2):133-140. PubMed ID: 30119941
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical studies.
Viscusi ER; Siccardi M; Damaraju CV; Hewitt DJ; Kershaw P
Anesth Analg; 2007 Nov; 105(5):1428-36, table of contents. PubMed ID: 17959978
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Hay Kraus BL
Vet Anaesth Analg; 2013 Jan; 40(1):28-34. PubMed ID: 23082784
[TBL] [Abstract][Full Text] [Related]
35. Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Beard TL; Michalsky C; Candiotti KA; Rider P; Wase L; Habib AS; Demitrack MA; Fossler MJ; Viscusi ER
Pain Ther; 2021 Jun; 10(1):401-413. PubMed ID: 33210266
[TBL] [Abstract][Full Text] [Related]
36. Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain.
Tan HS; Habib AS
Expert Opin Drug Saf; 2021 Nov; 20(11):1291-1298. PubMed ID: 34370562
[TBL] [Abstract][Full Text] [Related]
37. Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy.
Liu Y; Yang L; Tao SJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5697-5703. PubMed ID: 30229847
[TBL] [Abstract][Full Text] [Related]
38. Perioperative intravenous ketamine for acute postoperative pain in adults.
Brinck EC; Tiippana E; Heesen M; Bell RF; Straube S; Moore RA; Kontinen V
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012033. PubMed ID: 30570761
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
40. Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Vanniyasingam T; Devereaux PJ; Bhandari M; Thabane L
Br J Anaesth; 2019 Jun; 122(6):e107-e113. PubMed ID: 31027915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
